News Release

CINCINNATI--(BUSINESS WIRE)--Aug. 23, 2017-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September:

Wells Fargo Healthcare Conference
Location: Boston, MA
Date: Wednesday, September 6, 2017
Presentation: 10:15 a.m. ET
Speakers: Dr. August Troendle, President & Chief Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations

A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following each event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170823006067/en/

Source: Medpace Holdings, Inc.

Medpace Holdings, Inc.
Media Contact:
Mary Kuramoto, 513-579-9911 x12523
m.kuramoto@medpace.com
or
Investor Contact:
investor@medpace.com